DE60005351D1 - Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel - Google Patents
Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittelInfo
- Publication number
- DE60005351D1 DE60005351D1 DE60005351T DE60005351T DE60005351D1 DE 60005351 D1 DE60005351 D1 DE 60005351D1 DE 60005351 T DE60005351 T DE 60005351T DE 60005351 T DE60005351 T DE 60005351T DE 60005351 D1 DE60005351 D1 DE 60005351D1
- Authority
- DE
- Germany
- Prior art keywords
- blood
- compounds
- inhibiting
- formation
- thrombin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002059 diagnostic imaging Methods 0.000 title 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 7
- 210000004369 blood Anatomy 0.000 abstract 5
- 239000008280 blood Substances 0.000 abstract 5
- 230000002401 inhibitory effect Effects 0.000 abstract 5
- 230000015572 biosynthetic process Effects 0.000 abstract 4
- 108090000190 Thrombin Proteins 0.000 abstract 3
- 229960004072 thrombin Drugs 0.000 abstract 3
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 102000035195 Peptidases Human genes 0.000 abstract 2
- 210000001772 blood platelet Anatomy 0.000 abstract 2
- IHDKBHLTKNUCCW-UHFFFAOYSA-N 1,3-thiazole 1-oxide Chemical compound O=S1C=CN=C1 IHDKBHLTKNUCCW-UHFFFAOYSA-N 0.000 abstract 1
- 108090000317 Chymotrypsin Proteins 0.000 abstract 1
- 208000005189 Embolism Diseases 0.000 abstract 1
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- 102000009123 Fibrin Human genes 0.000 abstract 1
- 108010073385 Fibrin Proteins 0.000 abstract 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 1
- 108010088842 Fibrinolysin Proteins 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000004365 Protease Substances 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 108090000631 Trypsin Proteins 0.000 abstract 1
- 102000004142 Trypsin Human genes 0.000 abstract 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical class NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 abstract 1
- 230000002785 anti-thrombosis Effects 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 229940127219 anticoagulant drug Drugs 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 229960002376 chymotrypsin Drugs 0.000 abstract 1
- 238000000502 dialysis Methods 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229950003499 fibrin Drugs 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000011503 in vivo imaging Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940012957 plasmin Drugs 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000012588 trypsin Substances 0.000 abstract 1
- 229960001322 trypsin Drugs 0.000 abstract 1
- 108010036927 trypsin-like serine protease Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US14292999P | 1999-07-09 | 1999-07-09 | |
| PCT/US2000/040332 WO2001004117A1 (fr) | 1999-07-09 | 2000-07-07 | Inhibiteurs de protease heteroaryle et agents d'imagerie diagnostique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60005351D1 true DE60005351D1 (de) | 2003-10-23 |
Family
ID=22501854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60005351T Expired - Lifetime DE60005351D1 (de) | 1999-07-09 | 2000-07-07 | Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6420397B1 (fr) |
| EP (1) | EP1194428B1 (fr) |
| AT (1) | ATE250056T1 (fr) |
| CA (1) | CA2379416A1 (fr) |
| DE (1) | DE60005351D1 (fr) |
| WO (1) | WO2001004117A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE344246T1 (de) | 1997-11-26 | 2006-11-15 | Ortho Mcneil Pharm Inc | Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer |
| SI21097A (sl) | 2001-12-04 | 2003-06-30 | Univerza V Ljubljani | Inhibitorji trombina |
| US20040098106A1 (en) * | 2002-11-14 | 2004-05-20 | Williams Michael S. | Intraluminal prostheses and carbon dioxide-assisted methods of impregnating same with pharmacological agents |
| US7285287B2 (en) * | 2002-11-14 | 2007-10-23 | Synecor, Llc | Carbon dioxide-assisted methods of providing biocompatible intraluminal prostheses |
| US6932930B2 (en) * | 2003-03-10 | 2005-08-23 | Synecor, Llc | Intraluminal prostheses having polymeric material with selectively modified crystallinity and methods of making same |
| FR2857967B1 (fr) * | 2003-07-25 | 2015-04-24 | Centre Nat Rech Scient | Complexes de lanthanide, leur preparation et leurs utilisations |
| US9788539B2 (en) | 2011-05-17 | 2017-10-17 | Velico Medical, Inc. | Platelet protection solution having beta-galactosidase and sialidase inhibitors |
| CA2835434A1 (fr) | 2011-05-17 | 2012-11-22 | Velico Medical, Inc. | Entreposage ameliore de plaquettes a l'aide d'un inhibiteur de sialidase |
| CA2887083A1 (fr) | 2012-10-05 | 2014-04-10 | Velico Medical, Inc. | Solution additive plaquettaire comprenant un inhibiteur de beta-galactosidase |
| WO2014120886A1 (fr) | 2013-01-30 | 2014-08-07 | Velico Medical, Inc. | Solution additive plaquettaire ayant un peptide formant un hydrogel à auto-assemblage |
| US9901663B2 (en) | 2013-05-06 | 2018-02-27 | Abbott Cardiovascular Systems Inc. | Hollow stent filled with a therapeutic agent formulation |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4418052A (en) | 1980-08-12 | 1983-11-29 | Wong Dennis W | Diagnostic compositions and method for radiologic imaging of fibrinogen deposition in the body |
| US4957939A (en) | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
| US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| US4652440A (en) | 1984-05-03 | 1987-03-24 | Paik Chang H | Method of stably radiolabeling antibodies with technetium and rhenium |
| US4980148A (en) | 1985-02-06 | 1990-12-25 | Mallinckrodt, Inc. | Methods for enhancing magnetic resonance imaging |
| GB8506792D0 (en) | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
| US5011686A (en) | 1987-09-21 | 1991-04-30 | Creative Biomolecules, Inc. | Thrombus specific conjugates |
| US5002935A (en) | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
| ZA897514B (en) | 1988-10-07 | 1990-06-27 | Merrell Dow Pharma | Novel peptidase inhibitors |
| US5024829A (en) | 1988-11-21 | 1991-06-18 | Centocor, Inc. | Method of imaging coronary thrombi |
| US5122361A (en) | 1989-04-17 | 1992-06-16 | Trustees Of The University Of Pennsylvania | Dopamine receptor ligands and imaging agents |
| EP0604022A1 (fr) | 1992-12-22 | 1994-06-29 | Advanced Cardiovascular Systems, Inc. | Endoprothèse résorbable, à plusieurs couches, pour le maintien des vaisseaux, et sa méthode de fabrication |
| US5656600A (en) | 1993-03-25 | 1997-08-12 | Corvas International, Inc. | α-ketoamide derivatives as inhibitors of thrombosis |
| GB9318637D0 (en) | 1993-09-08 | 1993-10-27 | Ferring Res Ltd | Enzyme inhibitors |
| US6087479A (en) | 1993-09-17 | 2000-07-11 | Nitromed, Inc. | Localized use of nitric oxide-adducts to prevent internal tissue damage |
| US5466811A (en) | 1994-07-18 | 1995-11-14 | Merck & Co., Inc. | Dioxolenylmethyl carbamates pro moieties for amine drugs |
| ES2235174T3 (es) | 1994-10-17 | 2005-07-01 | Kabushikikaisha Igaki Iryo Sekkei | Stent liberador de medicamento. |
| US5643580A (en) | 1994-10-17 | 1997-07-01 | Surface Genesis, Inc. | Biocompatible coating, medical device using the same and methods |
| US5637113A (en) | 1994-12-13 | 1997-06-10 | Advanced Cardiovascular Systems, Inc. | Polymer film for wrapping a stent structure |
| MX9704439A (es) | 1994-12-13 | 1997-10-31 | Corvas Int Inc | Derivados heterociclicos aromaticos como inhibidores de enzima. |
| DE19514104C2 (de) | 1995-04-13 | 1997-05-28 | Behringwerke Ag | Beschichtung für in den Blutstrom oder in das Gewebe des menschlichen Körpers einbringbares Biomaterial |
| WO1997001338A1 (fr) | 1995-06-27 | 1997-01-16 | Merck & Co., Inc. | Inhibiteurs de la thrombine a base de pyridinone |
| CA2245811A1 (fr) | 1996-02-22 | 1997-08-28 | Merck & Co., Inc. | Inhibiteurs de pyridinone thrombine |
| AU722161B2 (en) | 1996-03-29 | 2000-07-20 | 3-Dimensional Pharmaceuticals, Inc. | Amidinohydrazones as protease inhibitors |
| EP0932615A1 (fr) * | 1996-10-11 | 1999-08-04 | Cor Therapeutics, Inc. | INHIBITEURS SELECTIFS DU FACTEUR Xa |
| US5792779A (en) * | 1997-02-19 | 1998-08-11 | Merck & Co., Inc. | Pyridinone thrombin inhibitors |
| ATE344246T1 (de) | 1997-11-26 | 2006-11-15 | Ortho Mcneil Pharm Inc | Heteroaryl aminoguanidin- und alkoxyguanidinderivate und ihre verwendung als proteasehemmer |
-
2000
- 2000-07-07 AT AT00960130T patent/ATE250056T1/de not_active IP Right Cessation
- 2000-07-07 EP EP00960130A patent/EP1194428B1/fr not_active Expired - Lifetime
- 2000-07-07 WO PCT/US2000/040332 patent/WO2001004117A1/fr not_active Ceased
- 2000-07-07 DE DE60005351T patent/DE60005351D1/de not_active Expired - Lifetime
- 2000-07-07 US US09/612,591 patent/US6420397B1/en not_active Expired - Lifetime
- 2000-07-07 CA CA002379416A patent/CA2379416A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2379416A1 (fr) | 2001-01-18 |
| US6420397B1 (en) | 2002-07-16 |
| EP1194428B1 (fr) | 2003-09-17 |
| WO2001004117A1 (fr) | 2001-01-18 |
| EP1194428A1 (fr) | 2002-04-10 |
| ATE250056T1 (de) | 2003-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO1998023565A3 (fr) | Aminoguanidines et alcoxyguanidines utilisees en tant qu'inhibiteurs de proteases | |
| IL139867A0 (en) | Pyrazinone derivatives and pharmaceutical compositions containing the same | |
| BR9815325A (pt) | Heteroaril, aminoguanidinas e alcóxiguanidinas eseu uso como inibidores da protease | |
| DE60122546D1 (en) | Aminopyridinyl-, aminoguanidinyl- und alkoxyguanidinyl- substituierte phenylacetamide als protease inhibitoren | |
| NO20004871D0 (no) | Benzamid- og sulfonamid-substituert aminoguanidiner og alkoksyguanidiner som protease inhibitorer | |
| DE60122750D1 (de) | Amidine-inhibitoren der serine-proteasen | |
| DE60005351D1 (de) | Heteroaryl protease inhibitoren und diagnostische bilderzeugungsmittel | |
| WO2002006248A3 (fr) | Pyrazinones oxyguanidines cycliques comme inhibiteurs de protease | |
| MXPA01008084A (es) | Heteroarilamidinas, metilamidinas y guanidinas como inhibidores de proteasa. | |
| TW200508200A (en) | Substituted phenyl acetamides and their use as protease inhibitors | |
| MXPA03000963A (es) | Inhibidores de oxiguanidina ciclica proteasa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |